Cerenome
CNSY
Cerenome (CNSY) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- $0.50
- EPS estimate
- −$2.25
- EPS surprise
- +122.22%
- Revenue surprise
- −6.48%
- Revenue
- $1.4M
- Revenue estimate
- $1.5M
- Reported
- Aug 14, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 14, 2025 | −$2.25 | $0.50 | +122.22% | $1.4M | SEC |
| Q1 2025 | May 30, 2025 | −$6.20 | −$29.75 | −379.69% | $1.1M | SEC |
| Q4 2024 | Mar 27, 2025 | −$12.42 | −$9.50 | +23.49% | $1.4M | SEC |
| Q3 2024 | Nov 14, 2024 | −$14.06 | −$9.25 | +34.22% | $1.5M | SEC |
| Q2 2024 | Aug 14, 2024 | −$13.25 | −$11.25 | +15.09% | $1.3M | SEC |
| Q1 2024 | May 15, 2024 | −$27.25 | −$18.75 | +31.19% | $1.7M | SEC |
| Q4 2023 | Mar 5, 2024 | −$26.81 | −$13.75 | +48.72% | $1.3M | SEC |
| Q3 2023 | Oct 31, 2023 | −$21.92 | −$25.00 | −14.07% | $1.2M | SEC |
| Q2 2023 | Aug 14, 2023 | −$43.17 | −$14.75 | +65.83% | $1.9M | SEC |
| Q1 2023 | Apr 20, 2023 | −$51.56 | −$52.50 | −1.82% | $506,000.00 | SEC |
| Q4 2022 | Feb 23, 2023 | −$56.25 | −$56.25 | +0.00% | $200,000.00 | SEC |
| Q3 2022 | Oct 20, 2022 | −$75.94 | −$71.25 | +6.17% | $100,000.00 | SEC |
| Q2 2022 | Jul 21, 2022 | −$81.25 | −$90.00 | −10.77% | $0.00 | SEC |
| Q1 2022 | Apr 21, 2022 | −$73.75 | −$71.25 | +3.39% | $0.00 | — |
| Q4 2021 | Feb 24, 2022 | −$88.13 | $3.75 | +104.26% | $0.00 | SEC |
| Q3 2021 | Oct 21, 2021 | −$90.00 | −$105.00 | −16.67% | $0.00 | SEC |
| Q2 2021 | Jul 22, 2021 | −$86.25 | −$93.75 | −8.70% | $0.00 | — |
| Q1 2021 | Apr 22, 2021 | −$136.25 | −$123.75 | +9.17% | $0.00 | — |
| Q4 2020 | Feb 22, 2021 | −$142.50 | −$251.25 | −76.32% | $0.00 | SEC |
| Q3 2020 | Oct 22, 2020 | −$168.75 | −$146.25 | +13.33% | $0.00 | SEC |
Quarterly revenue
Frequently asked questions
When did Cerenome (CNSY) last report earnings?
Cerenome last reported on Aug 14, 2025, covering fiscal Q2 2025.
Did CNSY beat earnings estimates?
Yes. Cerenome reported EPS of $0.50 for Q2 2025 against a −$2.25 estimate — a 122.22% beat.
How much revenue did CNSY report last quarter?
Cerenome reported $1.4M in revenue for Q2 2025, against a consensus estimate of $1.5M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.